A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients

por Jenum, Synne, Tonby, Kristian, Rueegg, Corina S., Rühwald, Morten, Kristiansen, Max P., Bang, Peter, Olsen, Inge Christoffer, Sellæg, Kjersti, Røstad, Kjerstin, Mustafa, Tehmina, Taskén, Kjetil, Kvale, Dag, Mortensen, Rasmus, Dyrhol-Riise, Anne Ma
Publicado 2021